ID

15837

Descrição

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00136487

Link

https://clinicaltrials.gov/show/NCT00136487

Palavras-chave

Versões (1)
  1. 15/06/2016 15/06/2016 -
Transferido a

15 de junho de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Prostate Cancer NCT00136487

Inglês

Eligibility Prostate Cancer NCT00136487

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of prostate cancer
Descrição

prostate cancer

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0600139
progression following prostatectomy or radiation to the prostate, defined as 3 psa rises, with each psa determination at least 4 weeks apart
Descrição

disease progression

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0138741
UMLS CUI [3,1]
C0033573
UMLS CUI [3,2]
C1522449
psa greater than or equal to 1.0 for men who had a prostatectomy
Descrição

psa

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0138741
psa greater than or equal to 3.0 for men who were treated with primary radiation therapy (external beam and/or brachytherapy)
Descrição

psa radiation therapy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0138741
UMLS CUI [1,2]
C1522449
psa doubling time between 6 and 24 months
Descrição

psa doubling time

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0138741
UMLS CUI [1,2]
C1521828
UMLS CUI [1,3]
C1518823
participants must be either fully active and asymptomatic or symptomatic but fully ambulatory
Descrição

fully active and asymptomatic

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0205177
UMLS CUI [2]
C0231221
adequate bone marrow function, kidney function and liver function as evidenced by laboratory results
Descrição

bone marrow function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005953
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of metastatic disease
Descrição

metastatic disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027627
prior hormonal therapy for recurrent prostate cancer
Descrição

hormonal therapy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0278838
prior chemotherapy for recurrent or metastatic prostate cancer
Descrição

chemotherapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0392920
radiation therapy within 6 months
Descrição

radiation therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1522449
patients allergic to non-steroidal anti-inflammatory drugs (nsaids), salicylates or sulfonamide-type medications who experience asthma or urticaria (hives) after taking aspirin or other nsaids
Descrição

allergy to nsaids

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003211
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0036077
patients taking a dose of aspirin greater than or equal to 325 mg a day within 4 weeks of study entry
Descrição

aspirin

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0178602
patients taking selective cox-2 inhibitors or any nsaids other than aspirin within 8 weeks of study entry
Descrição

selective cox-2 inhibitors

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1257954
patients taking fluconazole, lithium or warfarin
Descrição

fluconazole lithium or warfarin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0016277
UMLS CUI [2]
C0023870
UMLS CUI [3]
C0043031
history of gastrointestinal or abdominal ulceration or any history of significant gastrointestinal bleeding in the past 12 months
Descrição

ulceration or bleeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0237938
UMLS CUI [2]
C0017181
any history of myocardial infarction in the past 12 months
Descrição

myocardial infarction

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027051
any uncontrolled, serious medical or psychiatric illness
Descrição

serious medical or psychiatric illness

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
Voltar ao início da página

Similar models

Eligibility Prostate Cancer NCT00136487

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
disease progression
Item
progression following prostatectomy or radiation to the prostate, defined as 3 psa rises, with each psa determination at least 4 weeks apart
boolean
C0242656 (UMLS CUI [1])
C0138741 (UMLS CUI [2])
C0033573 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
psa
Item
psa greater than or equal to 1.0 for men who had a prostatectomy
boolean
C0138741 (UMLS CUI [1])
psa radiation therapy
Item
psa greater than or equal to 3.0 for men who were treated with primary radiation therapy (external beam and/or brachytherapy)
boolean
C0138741 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
psa doubling time
Item
psa doubling time between 6 and 24 months
boolean
C0138741 (UMLS CUI [1,1])
C1521828 (UMLS CUI [1,2])
C1518823 (UMLS CUI [1,3])
fully active and asymptomatic
Item
participants must be either fully active and asymptomatic or symptomatic but fully ambulatory
boolean
C0205177 (UMLS CUI [1])
C0231221 (UMLS CUI [2])
bone marrow function
Item
adequate bone marrow function, kidney function and liver function as evidenced by laboratory results
boolean
C0005953 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
metastatic disease
Item
evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
hormonal therapy
Item
prior hormonal therapy for recurrent prostate cancer
boolean
C0279025 (UMLS CUI [1,1])
C0278838 (UMLS CUI [1,2])
chemotherapy
Item
prior chemotherapy for recurrent or metastatic prostate cancer
boolean
C0392920 (UMLS CUI [1])
radiation therapy
Item
radiation therapy within 6 months
boolean
C1522449 (UMLS CUI [1])
allergy to nsaids
Item
patients allergic to non-steroidal anti-inflammatory drugs (nsaids), salicylates or sulfonamide-type medications who experience asthma or urticaria (hives) after taking aspirin or other nsaids
boolean
C0020517 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0036077 (UMLS CUI [2,2])
aspirin
Item
patients taking a dose of aspirin greater than or equal to 325 mg a day within 4 weeks of study entry
boolean
C0004057 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
selective cox-2 inhibitors
Item
patients taking selective cox-2 inhibitors or any nsaids other than aspirin within 8 weeks of study entry
boolean
C1257954 (UMLS CUI [1])
fluconazole lithium or warfarin
Item
patients taking fluconazole, lithium or warfarin
boolean
C0016277 (UMLS CUI [1])
C0023870 (UMLS CUI [2])
C0043031 (UMLS CUI [3])
ulceration or bleeding
Item
history of gastrointestinal or abdominal ulceration or any history of significant gastrointestinal bleeding in the past 12 months
boolean
C0237938 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
myocardial infarction
Item
any history of myocardial infarction in the past 12 months
boolean
C0027051 (UMLS CUI [1])
serious medical or psychiatric illness
Item
any uncontrolled, serious medical or psychiatric illness
boolean
C0009488 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial